Starting in 2001 with a small range of commodities for peptides, Iris Biotech GmbH developed its portfolio to a unique list of standard reagents and unusual building blocks extended by our custom synthesis service making us the number one address for any (un-)usual compound required for the modifica... Read more
This company has no teams yet
This company has no offices yet